特集 神経疾患治療の進歩 2017
認知症の治療の進歩
2018 年 35 巻 5 号 p. 590-592
詳細
2018 年 35 巻 5 号 p. 590-592
Dementia affects over 35 million people in the world with a rapidly increasing prevalence. Alzheimer's disease (AD) is the most common form of dementia. No fundamental treatment for AD has been established, and novel therapeutic strategies are under investigation. This progress has led to the development of numerous therapeutic strategies in the clinical testing. Immunotherapy against Aβ has been pursued extensively as a therapeutic approach to AD and others, and several other promising trials are currently ongoing. This review overviewed recent advances in larger clinical research in dementia.
